Emily Collin

Title: Emily Collin: Innovator in Porcine Pestivirus Research

Introduction

Emily Collin is a notable inventor based in Lenexa, Kansas. She has made significant contributions to the field of veterinary medicine, particularly in the area of porcine pestivirus. Her work focuses on developing immunogenic compositions and methods for vaccinating against this virus, which is crucial for the health of pig populations.

Latest Patents

Emily Collin holds a patent for her invention titled "Porcine pestvirus, vaccines, and assays." This patent describes atypical porcine pestivirus (APPV) and includes immunogenic compositions designed to induce an immune response against porcine pestivirus infection in pigs. The patent details various APPV antigenic agents, including isolated whole virus, derivatives, and functional fragments. Additionally, it outlines methods for vaccinating against porcine pestivirus infection, which can also be applied in clinical research and diagnostic methods using monoclonal antibodies that specifically bind to APPV epitopes. She has 1 patent to her name.

Career Highlights

Emily is affiliated with the Kansas State University Research Foundation, where she conducts her research. Her work has been instrumental in advancing the understanding and management of porcine pestivirus, which poses a significant threat to the swine industry.

Collaborations

Emily has collaborated with notable colleagues, including Ben Hause and Ying Fang, who have contributed to her research efforts in the field.

Conclusion

Emily Collin's innovative work in porcine pestivirus research highlights her dedication to improving animal health and advancing veterinary science. Her contributions are vital for the swine industry and demonstrate the importance of research in developing effective vaccines and diagnostic methods.